Ocriplasmin opens up new avenues in the therapy of vitreomacular traction

References

• Ponsioen TL, Hooymans JM, Los LI. Remodelling of the human vitreous and vitreoretinal interface – a dynamic process. Prog. Retin. Eye Res. 29(6), 580–595 (2010).
   PubMedGoogle Scholar
• Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog. Retin. Eye Res. 19(3), 323–344 (2000).
   PubMed Web of Science ®Google Scholar
• Le Goff MM, Bishop PN. Adult vitreous structure and postnatal changes. Eye (Lond.) 22(10), 1214–1222 (2008).
   PubMed Web of Science ®Google Scholar
• Foos RY, Wheeler NC. Vitreoretinal juncture. Synchysis senilis and posterior vitreous detachment. Ophthalmology 89(12), 1502–1512 (1982).
   PubMed Web of Science ®Google Scholar
• Sebag J. Age-related differences in the human vitreoretinal interface. Arch. Ophthalmol. 109(7), 966–971 (1991).
   PubMedGoogle Scholar
• Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefes Arch. Clin. Exp. Ophthalmol. 242(8), 690–698 (2004).
   Google Scholar
• Jaffe NS. Vitreous traction at the posterior pole of the fundus due to alterations in the vitreous posterior. Trans. Am. Acad. Ophthalmol. Otolaryngol. 71(4), 642–652 (1967).
   PubMedGoogle Scholar
• Irvine SR. A newly defined vitreous syndrome following cataract surgery interpreted according to recent concepts of the structure of the vitreous. Am. J. Ophthalmol. 35, 499–619 (1953).
   Google Scholar
• Reese AB, Jones IS, Cooper WC. Macular changes secondary to vitreous traction. Trans. Am. Ophthalmol. Soc. 64, 123–134 (1966).
   PubMedGoogle Scholar
• Johnson MW. Posterior vitreous detachment: evolution and complications of its early stages. Am. J. Opthamol. 149(3), 371–382.e1 (2010).
   Google Scholar
• Krebs I, Brannath W, Glittenberg C, Zeiler F, Sebag J, Binder S. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am. J. Ophthalmol. 144(5), 741–746 (2007).
   PubMed Web of Science ®Google Scholar
• Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104(3),473–478 (1997).
   PubMed Web of Science ®Google Scholar
• Chen W, Mo W, Sun K Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy. Curr. Eye Res. 34, 1057–1064 (2009).
   PubMed Web of Science ®Google Scholar
• Schneider EW, Johnson MW. Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review. Clin. Ophthalmol. 5, 1151–1165 (2011).
   Google Scholar
• De Smet MD, Valmaggia C, Zarranz-Ventura J Microplasmin: ex-vivo characterization of its activity in porcine vitreous. Invest. Ophthalmol. Vis. Sci. 50, 814–819 (2009).
   PubMed Web of Science ®Google Scholar
• Gandorfer A, Rohleder M, Sethi C, Posterior vitreous detachment induced by microplasmin. Invest. Ophthalmol. Vis. Sci. 45, 641–647 (2004).
   PubMed Web of Science ®Google Scholar
• de Smet MD, Jonckx B, Vanhove M, van Calster J, Stalmans P, Stassen JM. Pharmacokinetics of ocriplasmin in vitreous. Invest. Ophthalmol. Vis. Sci. 53(13), 8208–8213 (2012).
   PubMedGoogle Scholar
• Stalmans P, Benz MS, Gandorfer A MIVI-TRUST Study Group. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N. Engl J. Med. 367(7), 606–615 (2012).
   PubMed Web of Science ®Google Scholar
• Data on file. ThromboGenics, Inc. 2012.
   Google Scholar
• Dommke C, Turschner O, Stassen JM. Thrombolytic efficacy of recombinant human microplasmin in a canine model of copper coil-induced coronary artery thrombosis. J. Thromb. Thrombolysis 30,46–54 (2010).
   PubMedGoogle Scholar
• Lee SJ, Lee CS, Koh HJ. Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study. Am. J. Ophthalmol. 147 (4), 621–626.e1 (2009).
   PubMed Web of Science ®Google Scholar
• Maier M, Pfrommer S, Burzer S, Feucht N, Winkler von Mohrenfels C, Lohmann CP. Vitreomacular interface and posterior vitreomacular adhesion in exudative age-related macular degeneration (AMD): an OCT-based comparative study. Klin. Monbl. Augenheilkd 229(10), 1030–1035 (2012).
   PubMedGoogle Scholar
• Lee SJ, Koh HJ. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology 118(1), 101–110 (2011).
   PubMedGoogle Scholar
• Krebs I, Brannath W, Glittenberg C, Zeller F, Sebag J, Binder S. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am. J. Ophthalmol. 144(5), 741–746 (2007).
   PubMed Web of Science ®Google Scholar
• Goldenberg DT, Trese MT. Pharmacologic vitreodynamics and molecular flux. Dev. Ophthalmol. 44, 31–6 (2009).
   PubMedGoogle Scholar
• Goldenberg DT, Giblin FG, Cheng M. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes. Retina 31(2), 393–400 (2011).
   PubMed Web of Science ®Google Scholar
• Diabetic Retinopathy Clinical Research Network Writing Committee; Haller JA, Qin H, Apte RS et al. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117(6), 1087–1093 (2010).
   PubMed Web of Science ®Google Scholar
• Elbendary AM, Elwan MM, Azzam HA, Eldeeb DR. Predictability of vitreous detachment following intravitreal plasmin injection in diabetic macular edema associated with vitreomacular traction. Curr. Eye Res. 36(6),534–539 (2011).
   PubMed Web of Science ®Google Scholar